The Valley Desk

ArticleCancer discoveryPublished

NKG2A Is a Therapeutic Vulnerability in Immunotherapy Resistant MHC-I Heterogeneous Triple-Negative Breast Cancer

Read the publication ↗ Open access copy ↗

Regional connection

Verified An author affiliation on the Europe PMC record names University of Pennsylvania. Affiliation source

Publication record

Type
Article
Venue
Cancer discovery
Published
Subject terms
Killer Cells, Natural; CD8-Positive T-Lymphocytes; Animals; Humans; Mice; Immunotherapy; Triple Negative Breast Neoplasms; B7-H1 Antigen
PubMed ID
37791898
PubMed Central ID
PMC10850946
Added to directory
Source checked

Report a correction or request removal